Quanta Pharma Tirzepatide 30mg
Original price was: $125.00.$105.00Current price is: $105.00.
Tirzepatide 30mg
99.68%
30.49mg
Lyophilized Vial
On orders over £200
✓
Research Grade
UK Fast Dispatch
QR Verified
Description
IN SHORT
Quanta Pharma Tirzepatide 30mg is a synthetic dual agonist peptide studied for activity at both the GLP-1 and GIP receptor pathways. This research compound is supplied as a lyophilized 30mg vial and is independently laboratory verified at 99.68% purity.
Janoshik Lab Verified
Independent third-party laboratory testing.
99.68% Purity
30.49mg Actual Content
Verify the laboratory results at
janoshik.com/verify
using verification key:
38NQN8WMT3ZS.
Tested: May 2025
Quanta Pharma Tirzepatide 30mg is a synthetic peptide compound studied for its activity at both the GLP-1 and GIP receptor pathways. This Tirzepatide 30mg peptide is supplied as a lyophilized vial from Quanta Pharma and has been independently laboratory verified at 99.68% purity.
Tirzepatide is widely studied in laboratory research involving GLP-1 and GIP receptor activity, metabolic signalling and related physiological pathways. Its dual-receptor profile makes Tirzepatide 30mg a relevant compound for controlled laboratory research.
Tirzepatide 30mg Specifications
Tirzepatide
Dual Agonist
30mg/vial
99.68%
Lyophilized
30.49mg
Tirzepatide 30mg by Quanta Pharma
Research-grade lyophilized Tirzepatide supplied in a 30mg vial. The applicable batch documentation and independent laboratory verification information should be reviewed before use.
Tirzepatide Research Benefits
- Dual receptor activity – Tirzepatide is studied for its interaction with both GLP-1 and GIP receptor pathways.
- Metabolic signalling – Investigated in laboratory research involving pathways associated with metabolic regulation.
- GLP-1 receptor research – Studied for activity at the glucagon-like peptide-1 receptor.
- GIP receptor research – Investigated alongside GLP-1 activity to examine dual-receptor signalling.
- Research applications – Used as a research compound in controlled studies involving receptor biology and metabolic pathways.
How Tirzepatide Works
Tirzepatide is a peptide compound that acts as an agonist at two receptor pathways: GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide).
Its dual-receptor activity makes Tirzepatide relevant to laboratory research examining how GLP-1 and GIP signalling interact and contribute to metabolic processes.
Research involving Tirzepatide can examine receptor activity, intracellular signalling and related metabolic pathways under controlled laboratory conditions.
Tirzepatide 30mg UK
Tirzepatide 30mg is supplied as a lyophilized research compound in a 30mg vial. For researchers looking for Tirzepatide 30mg in the UK, product specifications, laboratory verification information and applicable documentation should be reviewed before use.
This product page provides information about the Tirzepatide 30mg vial, including its stated purity, actual content, format and independent laboratory verification details.
For Laboratory Research Use Only
NOT FOR HUMAN OR VETERINARY DIAGNOSTIC OR THERAPEUTIC USE.
This material is supplied exclusively for laboratory research purposes. It is not intended for human consumption, self-administration, diagnosis, treatment or prevention of disease.
Researchers should consult the applicable product documentation, safety information and local regulations before handling or working with this material.
Related products
-
Sale!
Quanta Pharma Tirzepatide 60mg
Original price was: $220.00.$185.00Current price is: $185.00. -
Sale!
Quanta Pharma Retatrutide 30mg
Original price was: $175.00.$155.00Current price is: $155.00. -
Sale!
Quanta Pharma Retatrutide 50mg
Original price was: $250.00.$220.00Current price is: $220.00.
Reviews
There are no reviews yet.